Role of diffusion-weighted MR imaging in assessing malignant versus benign skull-base lesions

A Abdel Razek1, A Mossad, M Ghonim

  • 1Department of Diagnostic Radiology, Mansoura Faculty of Medicine, Mansoura, Egypt. arazek@mans.eun.eg

La Radiologia Medica
|September 21, 2010
PubMed
Abstract

Insights

Diffusion-weighted MRI effectively distinguishes malignant from benign skull lesions. This noninvasive technique shows promise for characterizing skull-base tumors and assessing their pathological grade.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Skull-base lesions present diagnostic challenges.
  • Differentiating malignant from benign tumors is crucial for treatment planning.

Purpose of the Study:

  • To evaluate the efficacy of diffusion-weighted magnetic resonance (MR) imaging in differentiating malignant from benign skull lesions.
  • To assess the role of apparent diffusion coefficient (ADC) values in lesion characterization.

Main Methods:

  • Retrospective analysis of 45 patients with skull-base lesions.
  • Diffusion-weighted MR imaging with b-factors of 500 and 1,000 s/mm(2) was performed.
  • Apparent diffusion coefficient (ADC) maps were generated to calculate lesion ADC values.

Main Results:

  • Mean ADC value for malignant tumors was 1.002 × 10(-3) mm(2)/s, and for benign tumors was 1.63 × 10(-3) mm(2)/s.
  • A statistically significant difference (p=0.001) was observed in ADC values between malignant and benign lesions.
  • An ADC threshold of 1.3 × 10(-3) mm(2)/s achieved 94% accuracy, 94% sensitivity, and 93% specificity.

Conclusions:

  • Diffusion-weighted MR imaging is a valuable noninvasive tool for characterizing skull-base lesions.
  • This technique aids in differentiating malignant from benign tumors.
  • It shows potential for evaluating the pathological grading of malignant skull tumors.